EXETER, N.H.--(BUSINESS WIRE)--Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialty pharmaceutical company, announced the appointment of David C. Brush as the Company’s Vice President of Business Development and Strategic Planning, effective immediately. Brush will be responsible for developing Bentley’s growth opportunities, assessing the expansion of products in the U.S. as well as focusing on the Company’s drug delivery business.
